GLOBAL BIO-IMAGING MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2023 - 2030)

Regional Analysis

• North America is expected to be the largest market for bio-imaging during the forecast period, accounting for over 35.7% of the market share in 2023. The North America bio-imaging market is driven by several factors such as increasing demand for non-invasive diagnostic techniques, rising prevalence of chronic and lifestyle diseases, and others.
• Asia Pacific market is expected to be the second-largest market for bio-imaging market, accounting for over 25.2% of the market share in 2023. Technology advancement is a key driver propelling the Asia Pacific bio-imaging market. Manufacturers are continually working on developing innovative imaging systems with improved resolution, speed, and diagnostic capabilities. Artificial intelligence (AI) integration with imaging devices is also gaining traction.
• Europe market is expected to be the fastest-growing market for bio-imaging market, with a share of 19.0% during the forecast period. Europe bio-imaging market is driven by the opportunities due to ongoing research on nanoparticle-based bio-imaging, growing applications of AI and 3D bio-imaging, expansion in therapeutic applications, and untapped potential in certain European countries.

• North America: U.S. and Canada
• Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
• Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
• Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
• Middle East: GCC Countries, Israel, and Rest of Middle East
• Africa: South Africa, North Africa, and Central Africa